(Q38689655)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

Variable BCG efficacy in rhesus populations: Pulmonary BCG provides protection where standard intra-dermal vaccination fails (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Peter Beverley

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Clemens Kocken

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

16

Alan W Thomas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

14

Tom H M Ottenhoff

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Frank A W Verreck

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Richard A W Vervenne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Claudia C Sombroek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Ivanela Kondova

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Okke A Eissen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Vinod Sommandas

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Nicole M van der Werff

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Ernst Verschoor

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Gerco Braskamp

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Jaco Bakker

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Jan A M Langermans

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Peter J Heidt

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Klaas W van Kralingen

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

language of work or name

1 reference

20 February 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

46-57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

Variation in protection by BCG: implications of and for heterologous immunity

19 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

The success and failure of BCG - implications for a novel tuberculosis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Genome plasticity of BCG and impact on vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Vaccines against tuberculosis: where are we and where do we need to go?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Tuberculosis vaccines: a strategic blueprint for the next decade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

The non-human primate model of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Protective efficacy of recombinant BCG Tokyo (Ag85A) in rhesus monkeys (Macaca mulatta) infected intratracheally with H37Rv Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Demographic histories and patterns of linkage disequilibrium in Chinese and Indian rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Simultaneous immunization against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Enhanced survival of lung tissue-resident memory CD8⁺ T cells during infection with influenza virus due to selective expression of IFITM3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Mitochondrial DNA variation in Chinese and Indian rhesus macaques (Macaca mulatta).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Stereological analysis of bacterial load and lung lesions in nonhuman primates (rhesus macaques) experimentally infected with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Immunization by a bacterial aerosol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Early events in Mycobacterium tuberculosis infection in cynomolgus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Environmental effects on protection against Mycobacterium tuberculosis after immunization with Ad85A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Evidence for a role for interleukin-17, Th17 cells and iron homeostasis in protective immunity against tuberculosis in cynomolgus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Segmented filamentous bacteria take the stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Infection with Helicobacter pylori is associated with protection against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Differential response of the cynomolgus macaque gut microbiota to Shigella infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Pulmonary but Not Subcutaneous Delivery of BCG Vaccine Confers Protection to Tuberculosis-Susceptible Mice by an Interleukin 17-Dependent Mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Airborne immunization against tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in Cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Immune biology of macaque lymphocyte populations during mycobacterial infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Harnessing local and systemic immunity for vaccines against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

The immunological life cycle of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Early T-cell responses in tuberculosis immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Resident Th1-like effector memory cells in pulmonary recall responses to Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Genetic immunization in the lung induces potent local and systemic immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine: Evidence for transient t cell responses in peripheral blood and robust sustained responses in the lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Creativity in tuberculosis research and discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

Aerosol-Induced Tuberculosis in Subhuman Primates and the Course of the Disease After Intravenous BCG Vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.02.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TUBE.2017.02.003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28454649%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference